These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12824189)

  • 1. Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERK1/2 MAPK.
    Rubin J; Murphy TC; Zhu L; Roy E; Nanes MS; Fan X
    J Biol Chem; 2003 Sep; 278(36):34018-25. PubMed ID: 12824189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain.
    Kusumi A; Sakaki H; Kusumi T; Oda M; Narita K; Nakagawa H; Kubota K; Satoh H; Kimura H
    J Bone Miner Metab; 2005; 23(5):373-81. PubMed ID: 16133687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
    Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
    J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
    Matsumoto M; Sudo T; Saito T; Osada H; Tsujimoto M
    J Biol Chem; 2000 Oct; 275(40):31155-61. PubMed ID: 10859303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of extracellular signal-regulated kinase is involved in mechanical strain inhibition of RANKL expression in bone stromal cells.
    Rubin J; Murphy TC; Fan X; Goldschmidt M; Taylor WR
    J Bone Miner Res; 2002 Aug; 17(8):1452-60. PubMed ID: 12162499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption.
    Zheng H; Yu X; Collin-Osdoby P; Osdoby P
    J Biol Chem; 2006 Jun; 281(23):15809-20. PubMed ID: 16613848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
    Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1.
    Fisslthaler B; Benzing T; Busse R; Fleming I
    Nitric Oxide; 2003 Jun; 8(4):253-61. PubMed ID: 12895435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
    Eto M; Barandiér C; Rathgeb L; Kozai T; Joch H; Yang Z; Lüscher TF
    Circ Res; 2001 Sep; 89(7):583-90. PubMed ID: 11577023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism.
    Henriksen K; Karsdal M; Delaisse JM; Engsig MT
    J Biol Chem; 2003 Dec; 278(49):48745-53. PubMed ID: 14506249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation.
    Lorenz M; Wessler S; Follmann E; Michaelis W; Düsterhöft T; Baumann G; Stangl K; Stangl V
    J Biol Chem; 2004 Feb; 279(7):6190-5. PubMed ID: 14645258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism.
    Wyatt AW; Steinert JR; Wheeler-Jones CP; Morgan AJ; Sugden D; Pearson JD; Sobrevia L; Mann GE
    FASEB J; 2002 Oct; 16(12):1584-94. PubMed ID: 12374781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways.
    Davis ME; Cai H; Drummond GR; Harrison DG
    Circ Res; 2001 Nov; 89(11):1073-80. PubMed ID: 11717166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Biol Reprod; 2004 Mar; 70(3):785-96. PubMed ID: 14627548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.
    Yamamoto A; Miyazaki T; Kadono Y; Takayanagi H; Miura T; Nishina H; Katada T; Wakabayashi K; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2002 Apr; 17(4):612-21. PubMed ID: 11918218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p44/42 MAPK activation is necessary for receptor activator of nuclear factor-kappaB ligand induction by high extracellular calcium.
    Kim YH; Kim JM; Kim SN; Kim GS; Baek JH
    Biochem Biophys Res Commun; 2003 May; 304(4):729-35. PubMed ID: 12727216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
    Van Bezooijen RL; Papapoulos SE; Löwik CW
    Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.